uniQure prices public offering of shares at $47.50, aims to raise $300m
PositiveFinancial Markets

uniQure has successfully priced its public offering of shares at $47.50, aiming to raise an impressive $300 million. This move is significant as it reflects investor confidence in the biotechnology sector and provides uniQure with the necessary capital to advance its innovative therapies. The funds raised will likely support ongoing research and development, positioning the company for future growth and success.
— Curated by the World Pulse Now AI Editorial System